Researchers pooled testosterone measurements from 13 studies that used liquid chromatography-mass spectrometry (LC-MS/MS), the most accurate method available for measuring hormones. They included only men who were screened to be in good health, excluding those with obesity, chronic diseases, or medications that affect hormones.

In this healthy population, testosterone peaked at 15.4 nmol/L around age 19, decreased to about 13.0 nmol/L by age 40, and then remained flat through old age. The variation between individuals increased with age, but the average did not continue to fall.

This challenges the secular decline narrative by suggesting that the apparent population-level drop may simply reflect increasing rates of obesity, diabetes, and other health conditions in the general population rather than a true generational biological shift.

The same Danish population survey data that showed raw declines in testosterone also provided one of the strongest counterarguments. When researchers statistically removed the effect of rising BMI over the study period, the testosterone decline lost its statistical significance.

This is a critical finding because obesity rates have risen dramatically worldwide since the 1980s. Fat tissue contains an enzyme called aromatase that converts testosterone into estrogen, directly lowering circulating testosterone levels. More body fat means more conversion and lower testosterone - a well-established biological mechanism.

If the population has simply gotten heavier, and heavier people have lower testosterone as a direct physiological consequence, then the apparent "secular decline" may not reflect a mysterious environmental or generational shift but rather the predictable hormonal consequence of widespread weight gain.

The Healthy Man Study recruited men who rated their own health as very good or excellent and excluded those with chronic diseases, obesity, or hormone-affecting medications. Using the gold-standard LC-MS/MS method for testosterone measurement, researchers found that healthy men maintained relatively stable testosterone levels into older age.

This is a fundamentally different picture from population surveys that include everyone regardless of health status. The implication is that what appears to be a secular or age-related decline in testosterone may largely be a reflection of worsening population health - more obesity, more diabetes, more medication use, and more sedentary lifestyles.

If the "decline" disappears when you only look at healthy men, the problem may not be a mysterious environmental exposure but rather the well-documented deterioration in metabolic health across Western populations.

The Florey Adelaide Male Ageing Study followed 1,382 community-dwelling Australian men aged 35 and older for five years, measuring testosterone at baseline and follow-up. Rather than simply documenting decline, researchers asked what specific factors predicted it.

Changes in body weight, smoking behavior, and the development of depression each independently predicted testosterone decline over the five-year period. Men who maintained healthy weight, continued to exercise, and did not develop depression showed minimal testosterone decline.

The practical implication is that much of what looks like a secular decline may be reversible. Rather than a mysterious environmental toxin lowering testosterone across generations, the more straightforward explanation may be that each generation is heavier, less active, and more prone to metabolic disease than the last.

Two leading endocrinologists argued that modest testosterone reductions seen in overweight and obese men should be classified as a nongonadal illness syndrome rather than genuine hypogonadism. The key evidence: luteinizing hormone and follicle-stimulating hormone (brain signals that control testicular function) remain normal in most obese men with low testosterone.

If the testes themselves were failing or environmental toxins were damaging them, these brain signals would rise in compensation. The fact that they stay normal suggests the body is deliberately dialing down testosterone production in response to metabolic stress - a functional adaptation, not permanent damage.

Weight loss through diet or bariatric surgery reliably normalizes testosterone in these men, further supporting the idea that the "decline" is a symptom of metabolic disease rather than an irreversible generational shift requiring medical treatment.

Before roughly 2010, most clinical labs measured testosterone using immunoassays - antibody-based tests that are cheaper and faster but less accurate. Modern mass spectrometry methods (LC-MS/MS) are significantly more precise, especially at lower testosterone concentrations.

The systematic differences between old and new methods mean that comparing testosterone levels measured in the 1980s and 1990s with levels measured in the 2010s and 2020s is comparing apples to oranges. A man with the exact same true testosterone level could get a reading 20% lower on an old immunoassay than on a modern mass spectrometry test.

Most studies claiming a secular decline compare data collected across decades using different laboratory methods, different reference standards, and different quality control procedures. Without careful calibration between methods, apparent trends could be partly or wholly an artifact of measurement technology changing.

Researchers compared testosterone levels in older men across different geographic locations and racial/ethnic groups. Total testosterone varied by 18%, free testosterone by 25%, and dihydrotestosterone (another male hormone) by 42% depending on where men lived and their ethnicity.

Asian men in Hong Kong and Japan had roughly 20% higher testosterone than men from other populations studied. These geographic differences were not explained by differences in body weight, health conditions, or other measured factors.

If testosterone levels vary this dramatically between populations for reasons that are not well understood, the idea of a universal "decline" becomes harder to sustain. What might appear as a secular decline in one country could be a statistical artifact in another. The narrative of a global testosterone crisis may reflect selective attention to studies from specific Western populations rather than a truly worldwide phenomenon.

Researchers pooled results from multiple studies examining what happens to testosterone when obese men lose weight. Both approaches - calorie restriction and surgical weight loss - produced significant increases in total testosterone. Bariatric surgery, which produces larger and more sustained weight loss, had a stronger effect.

Critically, the brain hormones that regulate testicular function (LH and FSH) remained normal in most obese men before weight loss. This confirms the testosterone suppression was a functional response to excess fat tissue and its hormone-converting enzymes, not damage to the testes or the brain''s hormonal control center.

If the secular decline in testosterone were caused by environmental toxins damaging the reproductive system, weight loss would not be expected to reverse it. The fact that it does strongly supports the interpretation that population-level testosterone decline is primarily a metabolic consequence of the obesity epidemic.

Mendelian randomization is a technique that uses genetic variants as natural experiments to establish cause and effect. Because genes are randomly assigned at conception, they are not affected by the same lifestyle and environmental confounders that plague observational studies. Researchers used genetic variants known to influence BMI to test whether higher BMI causally lowers testosterone.

The analysis confirmed a causal direction: genetically predicted higher BMI led to lower testosterone, but genetically predicted lower testosterone did not lead to higher BMI. Reducing BMI from 30 (obese) to 25 (normal weight) was predicted to increase testosterone by about 13%.

This is some of the strongest evidence that obesity causes low testosterone rather than the reverse. Since obesity rates have roughly tripled in many Western countries since the 1970s, the obesity epidemic alone could plausibly account for much of the observed secular decline in testosterone without needing to invoke environmental endocrine disruptors or other speculative causes.